- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medrad offers new CT injector
A new CT injection system promises unprecedented performance, according to its developer Medrad. The Stellant Injection System features saline flush, a pressure monitor graph, improved syringe design, syringe autoload, and the ability to upgrade from
A new CT injection system promises unprecedented performance, according to its developer Medrad. The Stellant Injection System features saline flush, a pressure monitor graph, improved syringe design, syringe autoload, and the ability to upgrade from single to dual injection. Its ability to precisely deliver contrast fluid under multiple CT protocols matches the speed of the new class of multidetector CT scanners. Stellant is considered especially suited to trauma, angiography, and cardiology exams, which incorporate demanding protocols with saline flush capability.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
